Back

Comprehensive multicenter evaluation of drug-coated balloon angioplasty in de novo and in-stent restenosis lesions

20 February 2026 (12:00 - 13:00)
Organised by: Logo
Congress Presentation Part of: Poster session (2) - Interventional cardiology (3) Percutaneous Coronary Intervention (PCI) EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Fotios Toulgaridis

Sismanoglio General Hospital of Attica, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Associate Professor B. Zafirovska Taleska (Skopje, MK)
Abstract Slides
Presentation thumbnail
Doctor C. Skos (Vienna, AT)
Abstract
Presentation thumbnail
Doctor M. Hassanin (Zagazig, EG)
Abstract Slides
Presentation thumbnail
Doctor M. Marchetta (Rome, IT)
Abstract Slides
Presentation thumbnail
Doctor A. Giuca (Leiden, NL)
Abstract

Access the full session

Session thumbnail
Poster session (2) - Interventional cardiology (3)

The Event

Event poster

EAPCI Summit 2026

20 February 2026 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Lesion preparation as an independent determinant of outcomes after drug-coated balloon angioplasty: evidence from clinical, angiographic and functional assessment in observational cohort
19 February 2026
thumbnail
Congress Presentation
Head to head comparison of limus vs paclitaxel-coated balloons (DCBs) in the treatment of in-stent restenosis: a meta-analysis
1 September 2025
thumbnail
Congress Presentation
REC-CAGEFREE I - Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of de novo coronary artery lesions: a multicenter, non-inferiority trial
2 September 2024
thumbnail
Congress Presentation
Predictors, feasibility and outcomes of coronary interventions up to 3 years after TAVI with a balloon-expandable valve. Results from a large European multicenter registry.
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources